Skip to main content
Clinical Trials/NCT00550498
NCT00550498
Terminated
Phase 1

Phase 1 Study of Bone Marrow - Derived Stem Cell in the Treatment of Ocular Lesions of Behcet's Disease

Tehran University of Medical Sciences1 site in 1 country5 target enrollmentDecember 2007

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Retinitis
Sponsor
Tehran University of Medical Sciences
Enrollment
5
Locations
1
Primary Endpoint
1- Visual acuity by ETDRS (Early Treatment of Diabetic Retinopathy Study). 2- Retinal state and retinal edema by Color Photography, Multifocal Electroretinography, and OCT (Optic Coherent Tomography).
Status
Terminated
Last Updated
10 years ago

Overview

Brief Summary

The purpose of this study is to find if autologous stem cell transplantation can stop the progression of intractable eye lesions of Behcet's Disease or even to improve it.

Detailed Description

To test in a pilot study the effect of autologous stem cell transplantation in stopping the progression of retinal damage of eye lesions in Behcet's Disease by repairing the vascular damage, and possibly to improve the lesions.

Registry
clinicaltrials.gov
Start Date
December 2007
End Date
July 2013
Last Updated
10 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Behcet's Disease
  • Fulfilling the International Criteria for behcet's Disease (ICBD)
  • Ocular lesions with retinal vasculitis
  • Resistant to at least 3 months of combination therapy with pulse cyclophosphamide (1g/monthly), azathioprine (3 mg/kg/daily), and prednisolone 0.5 mg/kg/daily
  • Visual acuity not less than 4 meters finger count
  • Retinal edema confirmed by color photography and OCT

Exclusion Criteria

  • No Vision
  • Active posterior uveitis
  • Fundus not visible

Outcomes

Primary Outcomes

1- Visual acuity by ETDRS (Early Treatment of Diabetic Retinopathy Study). 2- Retinal state and retinal edema by Color Photography, Multifocal Electroretinography, and OCT (Optic Coherent Tomography).

Time Frame: 12 months

Study Sites (1)

Loading locations...

Similar Trials